Aclaris Therapeutics, Inc.

ACRS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$24,570$39,878$45,277$27,349
Short-Term Investments$89,024$79,228$172,294$164,065
Receivables$318$298$484$623
Inventory$0$0$0$0
Other Curr. Assets$12,039$9,452$13,495$12,995
Total Curr. Assets$125,951$128,856$231,550$205,032
Property Plant & Equip (Net)$1,008$1,620$1,099$1,335
Goodwill$0$0$0$0
Intangibles$0$269$6,973$7,048
Long-Term Investments$90,302$62,771$12,242$34,242
Tax Assets$0$0$0$0
Other NC Assets$3,066$3,889$2,732$3,554
Total NC Assets$94,376$68,549$23,046$46,179
Other Assets$0$0$0$0
Total Assets$220,327$197,405$254,596$251,211
Liabilities
Payables$4,690$8,878$10,351$9,985
Short-Term Debt$0$426$684$693
Tax Payable$0$0$0$0
Deferred Revenue$3,890$0$0$0
Other Curr. Liab.$23,016$21,648$10,903$12,253
Total Curr. Liab.$31,596$30,952$21,938$22,931
LT Debt$0$0$0$0
Deferred Rev, NC$20,038$0$0$0
Deferred Tax Liab, NC$0$0$367$367
Other NC Liab.$13,139$9,274$34,670$30,572
Total NC Liab.$33,177$9,274$35,037$30,939
Other Liabilities$0$0$0$0
Cap. Leases$0$426$684$693
Total Liabilities$64,773$40,226$56,975$53,870
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$902,861-$770,796-$682,315-$595,407
AOCI$97-$106-$897-$224
Other Equity$1,058,317$928,080$880,832$792,971
Total Equity$155,554$157,179$197,621$197,341
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$220,327$197,405$254,596$251,211
Net Debt-$24,570-$39,452-$44,593-$26,656
Aclaris Therapeutics, Inc. (ACRS) Financial Statements & Key Stats | AlphaPilot